Currently also enrolled in Masters in Public Health (MPH) program from The College of New Jersey, New Jersey.

Sehrish has established the basic foundation of research and development as per the principles of QbD covering both the formulation development and analytical method development aspects needed to compile the product dossier (CTD) for stringent regulatory authorities. She has also designed strategic project plans for pharmaceutical product development and delivered as per the commitment.

Sehrish held position of increasing responsibility, the latest being Head RND Global Markets and Regulatory Affairs. Playing a  primary role in revamping the product development project management for accelerated access of much needed drugs like COVID-19 related generic products and Anti-Tb drugs for WHO Prequalification.  Her wide interest in transformational leadership and innovation approach paved the way to add a new dimension and upgraded systems in RND, operations and commercialization & regulatory business development.